• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病和皮质激素治疗作为导致阿仑膦酸钠相关性颌骨坏死的危险因素:一项 Wistar 大鼠研究。

Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats.

机构信息

Dental College, Pontifical Catholic University of Rio Grande do Sul, Hospital São Lucas, Porto Alegre, RS, Brazil.

出版信息

Head Neck. 2014 Jan;36(1):84-93. doi: 10.1002/hed.23260. Epub 2013 May 4.

DOI:10.1002/hed.23260
PMID:23649954
Abstract

BACKGROUND

The purpose of this study was to investigate the influence of diabetes and corticotherapy on the development of osteonecrosis of the jaws associated with sodium alendronate.

METHODS

Rats were allocated into 4 groups of 11 animals each, representing different treatments: (1) alendronate; (2) alendronate and corticotherapy; (3) alendronate and diabetes; and (4) control. Tooth extractions were performed in all animals, and histological analysis was performed by hematoxylin and eosin staining and immunohistochemistry using anti-bone morphogenetic protein (BMP)-4 and anti-matrix metalloproteinase (MMP)-13 antibodies.

RESULTS

On hematoxylin and eosin analysis, proportions of inflammatory infiltrate, microbial colonies, and osteonecrosis were significantly greater in the diabetes group. BMP-4 expression in connective tissue was higher in the corticosteroid group than the alendronate group. There were no significant differences between the other groups. MMP-13 expression did not differ between the groups analyzed.

CONCLUSION

Diabetes but not corticotherapy is associated with jaw osteonecrosis in rats undergoing alendronate therapy and subjected to tooth extractions.

摘要

背景

本研究旨在探讨糖尿病和皮质激素治疗对接受阿仑膦酸钠治疗并接受拔牙的大鼠颌骨骨坏死发展的影响。

方法

将大鼠分为 4 组,每组 11 只,分别代表不同的治疗方法:(1)阿仑膦酸钠;(2)阿仑膦酸钠和皮质激素治疗;(3)阿仑膦酸钠和糖尿病;和(4)对照组。所有动物均进行拔牙,通过苏木精和伊红染色和抗骨形态发生蛋白(BMP)-4 和基质金属蛋白酶(MMP)-13 抗体的免疫组织化学分析进行组织学分析。

结果

在苏木精和伊红分析中,糖尿病组的炎症浸润、微生物菌落和骨坏死的比例明显更高。与阿仑膦酸钠组相比,皮质激素组结缔组织中 BMP-4 的表达更高。其他组之间没有显着差异。分析的各组之间 MMP-13 表达没有差异。

结论

在接受阿仑膦酸钠治疗并接受拔牙的大鼠中,糖尿病而非皮质激素治疗与颌骨骨坏死有关。

相似文献

1
Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats.糖尿病和皮质激素治疗作为导致阿仑膦酸钠相关性颌骨坏死的危险因素:一项 Wistar 大鼠研究。
Head Neck. 2014 Jan;36(1):84-93. doi: 10.1002/hed.23260. Epub 2013 May 4.
2
Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.在大鼠模型中,双膦酸盐诱导的下颌骨坏死首先发生在骨暴露之后。未暴露的骨中没有原发性坏死。
J Oral Pathol Med. 2012 Jul;41(6):494-9. doi: 10.1111/j.1600-0714.2011.01125.x. Epub 2012 Jan 23.
3
Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.口服双膦酸盐治疗骨质疏松症导致的颌骨骨坏死:87 例意大利多医院回顾性研究。
Eur J Intern Med. 2013 Dec;24(8):784-90. doi: 10.1016/j.ejim.2013.05.011. Epub 2013 Jun 12.
4
Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.唑来膦酸相关性颌骨坏死。大鼠拔牙实验模型。
J Craniomaxillofac Surg. 2014 Sep;42(6):744-50. doi: 10.1016/j.jcms.2013.11.005. Epub 2013 Nov 15.
5
Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.双膦酸盐与颌骨骨坏死的关系:Wistar 大鼠的研究。
Head Neck. 2011 Feb;33(2):199-207. doi: 10.1002/hed.21422.
6
Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.创伤与双膦酸盐相关骨坏死之间关系的实验研究
Niger J Clin Pract. 2014 Sep-Oct;17(5):559-64. doi: 10.4103/1119-3077.141417.
7
Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate.阿仑膦酸钠、雷洛昔芬和雷奈酸锶治疗大鼠拔牙部位的形态学和免疫组织化学特征。
Clin Oral Investig. 2021 May;25(5):2705-2716. doi: 10.1007/s00784-020-03585-x. Epub 2020 Sep 23.
8
Alendronate-associated osteonecrosis of the jaws: a review of the main topics.阿仑膦酸钠相关性颌骨坏死:主要议题综述。
Med Oral Patol Oral Cir Bucal. 2014 Mar 1;19(2):e106-11. doi: 10.4317/medoral.19094.
9
Bisphosphonate-Related Osteonecrosis of the Jaw After Tooth Extraction.拔牙后双膦酸盐相关颌骨坏死
J Craniofac Surg. 2015 Oct;26(7):e606-8. doi: 10.1097/SCS.0000000000002051.
10
Bisphosphonates and osteonecrosis of the maxilla.双膦酸盐与上颌骨坏死
QJM. 2014 Apr;107(4):311. doi: 10.1093/qjmed/hct128. Epub 2013 May 24.

引用本文的文献

1
The effects of sodium alendronate on socket healing after tooth extraction: a systematic review of animal studies.阿仑膦酸钠对拔牙后牙槽窝愈合影响的动物研究系统评价。
Braz Oral Res. 2024 May 13;38:e038. doi: 10.1590/1807-3107bor-2024.vol38.0038. eCollection 2024.
2
Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.啮齿动物作为研究拔牙相关药物性颌骨坏死的动物模型:结局评估。
Arch Oral Biol. 2024 Mar;159:105875. doi: 10.1016/j.archoralbio.2023.105875. Epub 2023 Dec 26.
3
The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice.
二甲双胍和阿仑膦酸盐对减轻糖尿病小鼠骨质流失及改善糖代谢的作用。
Aging (Albany NY). 2022 Jan 14;14(1):272-285. doi: 10.18632/aging.203729.
4
Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).药物相关性颌骨坏死(MRONJ)的临床前模型。
Bone. 2021 Dec;153:116184. doi: 10.1016/j.bone.2021.116184. Epub 2021 Sep 11.
5
Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw.在接受唑来膦酸盐治疗的小鼠中拔牙会增加炎性细胞因子水平并促进颌骨坏死。
J Bone Miner Metab. 2021 May;39(3):372-384. doi: 10.1007/s00774-020-01174-2. Epub 2020 Nov 17.
6
Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate.阿仑膦酸钠、雷洛昔芬和雷奈酸锶治疗大鼠拔牙部位的形态学和免疫组织化学特征。
Clin Oral Investig. 2021 May;25(5):2705-2716. doi: 10.1007/s00784-020-03585-x. Epub 2020 Sep 23.
7
Review and update on drugs related to the development of osteonecrosis of the jaw.药物相关性颌骨骨坏死的研究进展与更新。
Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25(1):e71-e83. doi: 10.4317/medoral.23191.
8
Refractory healing after surgical therapy of osteonecrosis of the jaw: associated risk factors in aged patients.颌骨骨坏死手术后治疗后难治性愈合:老年患者的相关危险因素。
Clin Interv Aging. 2019 May 6;14:797-804. doi: 10.2147/CIA.S200455. eCollection 2019.
9
Increased risk of bisphosphonate-related osteonecrosis of the jaw in patients with Sjögren's syndrome: nationwide population-based cohort study.干燥综合征患者发生双膦酸盐相关性颌骨骨坏死的风险增加:基于全国人群的队列研究。
BMJ Open. 2019 Feb 13;9(2):e024655. doi: 10.1136/bmjopen-2018-024655.
10
Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials.药物相关性颌骨坏死的发病机制:体内和体外试验的比较研究
J Int Med Res. 2018 Oct;46(10):4277-4296. doi: 10.1177/0300060518788987. Epub 2018 Aug 9.